June 29, 2015 | The international healthcare company Merck announced that it will acquire Qlight Nanotech. Though the financial details of the deal were not disclosed, Merck will require the remaining stake in the Jerusalem-based company to control 100 percent of the company. Qlight Nanotech is the developer of semiconductor nanocyrstals and Merck hopes to use their technology to develop liquid crystal displays and OLED technology. The deal was announced at today’s (Monday’s) ‘Made in Germany’ event in Tel Aviv.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

AI Can Predict Future Heart Attacks By Analyzing CT Scans
October 01, 2023

Israeli Startups Create Powerful Drone-Detecting Software
September 28, 2023

Model Sees Daylight As Boost For Hospitalized Patients’ Health
September 28, 2023

Solar Panels On A Roll Certified As Safe For Use In US, Europe
September 28, 2023
Facebook comments